Selected publications
-
HER1/EGFR inhibitor-associated rash: Future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
Oncologist.
2005
Review
GET IT
Times cited: 228 -
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 1.
Journal of Clinical Oncology.
2004
Academic Article
GET IT
Times cited: 1603